Skip to main content
TipRanks
Go Ultimate75% OFF

Rockwell Med (RMTI) Stock Price & Analysis

1,236 Followers

RMTI Stock Chart & Stats

$6.10-$0.51(-7.72%)
At close: 4:00 PM EST
$6$7$8Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$6.06 - $7.27
52-Week Range
$4.89 - $12.90
Previous Close
$6.61
Volume
N/A
Average Volume (3M)
27.25K
Market Cap
$26.64M
Enterprise Value
$24.91M
Total Cash (Recent Filing)
$22.54M
Total Debt (Recent Filing)
$13.53M
Price to Earnings (P/E)
―
Beta
0.60
Next Earnings
Apr 01, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Sales And Customer Expansion

Strong quarterly growth reflects both customer acquisition and deeper purchasing by major dialysis providers, supporting repeat demand for essential treatment products. Broader adoption across clinics can improve utilization of Rockwell’s portfolio and create a durable base for future revenue expansion.

Improved Balance-sheet Strength

Manageable leverage gives Rockwell greater financial flexibility than in 2021–2022, when leverage was extreme and equity was thin. A stronger capital base can help the company fund operations, pursue strategic initiatives, and absorb execution volatility without relying as heavily on additional borrowing.

Potential Global Platform Expansion

The proposed acquisition could materially broaden Rockwell from a more focused concentrates business into a global hemodialysis platform with recurring revenue characteristics. Added products, customers, manufacturing capacity, and distribution may improve scale and cross-selling if the transaction closes and integration is effective.

Bears Say

Persistent Unprofitability

Rockwell remains loss-making despite improvement from earlier periods, and its low gross margin leaves limited room to cover operating expenses. Continued negative returns on equity indicate that the business is not yet converting its capital base into sustainable earnings, weakening internal funding capacity.

Acquisition And Outlook Uncertainty

Withdrawing guidance makes near-term revenue, margin, and cash-flow planning less predictable while acquisition-related expenses continue. The pending closing also leaves the expected strategic scale unrealized for now, exposing results to transaction timing, approval, and execution uncertainty over coming quarters.

Cost Pressure And Declining Cash

Input and freight inflation directly reduced gross-margin performance, while the lower cash balance shows that working-capital needs and automation spending are consuming liquidity. Unless pricing, productivity, or supply-chain actions offset these pressures, they can delay the path to durable profitability.

Rockwell Med News

RMTI FAQ

What was Rockwell Med’s price range in the past 12 months?
Rockwell Med lowest stock price was $4.89 and its highest was $12.90 in the past 12 months.
What is Rockwell Med’s market cap?
Rockwell Med’s market cap is $26.64M.
When is Rockwell Med’s upcoming earnings report date?
Rockwell Med’s next earnings report is estimated for Apr 01, 2027 (not yet confirmed), which is in 133 days.
How were Rockwell Med’s earnings last quarter?
Rockwell Med released its earnings results on Nov 12, 2026. The company reported -$0.59 earnings per share for the quarter, missing the consensus estimate of -$0.18 by -$0.41.
Is Rockwell Med overvalued?
According to Wall Street analysts Rockwell Med’s price is currently Undervalued.
Does Rockwell Med pay dividends?
Rockwell Med does not currently pay dividends.
What is Rockwell Med’s EPS estimate?
Rockwell Med’s EPS estimate is -0.43.
How many shares outstanding does Rockwell Med have?
Rockwell Med has 4,030,465 shares outstanding.
What happened to Rockwell Med’s price movement after its last earnings report?
Rockwell Med reported an EPS of -$0.59 in its last earnings report, missing expectations of -$0.18. Following the earnings report the stock price went up 4.237%.
Which hedge fund is a major shareholder of Rockwell Med?
Hedge funds hold Rockwell Med shares: the largest hedge-fund position in Rockwell Med is 72,328,489 shares, and hedge funds decreased their holdings by 9.2K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology